Answer
Setmelanotide selectively activates brain MC4 receptors, which regulate hunger, satiety and energy expenditure, and is believed to restore pathway activity in diseases involving insufficient MC4 receptor activation, reducing hunger and promoting weight loss through decreased calorie intake and increased energy expenditure.
Sources for this answer
- IMCIVREE 10 mg/ml solution for injectionRhythm Pharmaceutical UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 10Document updated
Sources checked